Supply Issues Eurosurgical Ltd Amniocentesis Needle FPH85065 (ICN 3475)

Change:

• The supplier Eurosurgical Ltd has informed us of a supply issue with its amniocentesis needle.
• There is one product code affected:
  • FPH85065 − Amniocentesis needle 21g With 15.1cm needle guide 18g For chorionic villus sampling – 20cm sampling needle echogenic tip and marker.
• The supply issue is due to supplier manufacturing issues.

Impact:

• FPH85065 is currently suspended and unavailable to order.
• Potential indirect alternative products are available to order through our online catalogue:
• • FNB85328 – Amniocentesis needle 21g x 180mm with stylet and luer lock
  • FNB85330 – Amniocentesis needle 21g x 150mm with stylet and luer lock.
• The available alternative devices are intended for amniocentesis procedures only. They are not suitable for chorionic villus sampling (CVS) procedures.
• Customers should review local clinical requirements before use and ensure that the alternative device is appropriate for the intended procedure to maintain patient safety and minimise disruption to patient care.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 1 October 2026.

Next Steps:               

• Customers are advised to log into our website to view the potential indirect alternative products.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.